IP Library Granted Patent US 8,524,215
Granted Patent B2
US 8,524,215 · App. 13/193,958 · Granted Sep 3, 2013

Absorbable PEG-based hydrogels

Inventors: Chee-Youb Won (Belle Mead, NJ); Helen Cui (Basking Ridge, NJ)
Assignee: Janssen Biotech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,215
App. No.
13/193,958
Granted
Sep 3, 2013
Kind
B2
Abstract

An absorbable PEG-based hydrogel prepared from a multi-arm-PEG-vinylsulfone having about 3 to about 8 arms and a multi-arm-PEG-R-sulfhydryl having about 3 to about 8 arms; where R is defined as an ester linkage, such as carboxylate ester, lactate ester, and isobutyrate ester have been disclosed. Additionally, sustained release compositions that are prepared from an absorbable PEG-based hydrogel and a protein have been disclosed which provide sustained release of proteins and peptides.

Claims (7)

1. A method of sustained release of a protein comprising the steps of:

providing a sustained release composition comprising, a PEG-based hydrogel comprising, the reaction product of a multi-arm-PEG-vinylsulfone having about 3 to about 8 arms and a multi-arm-PEG-R-sulfhydryl having about 3 to about 8 arms; wherein R si an ester linkage selected from the group consisting of carboxylate ester, lactate ester, and isobutyrate ester; and a protein, implanting the sustained release composition, and releasing the protein from the composition for up to about 180 days.

2. The method of sustained release of a protein of claim 1 wherein the N-arm-PEG-vinylsulfone and the N-arm-PEG-R-sulfhydryl are in a ratio of from about 1:1 to about 1:2.

3. The method of sustained release of a protein of claim 1 wherein, the molecular weight of the PEG is from about 2000 Da to about 40 kDa.

4. The method of sustained release of a protein of claim 1 wherein the protein is an anti-IL-6 antibody.

5. The method of sustained release of a protein of claim 1 , wherein the PEG-based hydrogel further comprises an excipient.

6. The method of sustained release of a protein of claim 5 , where the excipient is cyclodextrin.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2013
From: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
To: JANSSEN BIOTECH, INC.
Reel/Frame 029596/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2012
From: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC
To: JANSSEN BIOTECH, INC.
Reel/Frame 029496/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2011
From: WON, CHEE-YOUB; CUI, HELEN
To: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICONE, LLC
Reel/Frame 027053/0355 →
Continuity (2)
Provisional Application 61369818 · Aug 2, 2010
Related Publication 20120027775A1 · Feb 2, 2012